aluates Reports

$ 0.0

Automative

Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Research Report 2024

Published Date: April 2024

Report Code: QYRE-Auto-24R5886

Global Cystic Fibrosis Mucoviscoidosis Testing Market Insights and Forecast to 2028

BUY CHAPTERS

Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Research Report 2024

Code: QYRE-Auto-24R5886

Report

April 2024

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Vertex Pharmaceuticals

Abbott

Pfizer Inc

NovaBiotics Ltd

Cystic Fibrosis Foundation

Galapagos

Cystic Fibrosis (Mucoviscoidosis) Testing Market

Cystic Fibrosis, also known as mucoviscoidosis, is an inherited genetic disorder that affects the secretory glands, including mucus and sweat glands. It mainly affects the lungs and digestive system. An individual suffering from cystic fibrosis show characteristic symptoms, such as, secretion of thick and sticky mucus. The disease develops over a period of time in the lungs and blocks the tubes that carry air in and out. Increased secretion of thick mucus accelerates the growth of bacteria and hence, gives rise to serious lung infections. Some of the major symptoms of cystic fibrosis include persistent cough, constant lung infection, salty tasting skin, problem in breathing, bulky stools, difficulty in bowel movements, poor growth and poor weight gain. Some of the tests available for cystic fibrosis are newborn screening, sweat test, chest x-ray, lung function tests, and genetic testing. Cystic fibrosis can be divided into three segments, namely, cystic fibrosis mutations, curable type of cystic fibrosis, and rare type of cystic fibrosis. Some of the treatment methods for cystic fibrosis are chest physical therapy (CPT), exercise, consumption of antibiotics, lung transplant and postural drainage.

The global Cystic Fibrosis (Mucoviscoidosis) Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

Major driving factors for the growth of the cystic fibrosis market are increasing number of patients suffering from cystic fibrosis, rising need and demand for sophisticated testing tools, and increased government funding for the development of genetic testing. Moreover, every company wants to grow and develop by using pharmacogenomic diagnostic tools, so that they have an enviable position in the existing market. Rapid adoption of potentially advanced tests to diagnose cystic fibrosis and increasing awareness and affordability of the people across geographies will continually provide growth towards this market. On the other hand, factors like huge amount of capital involved and few adverse effects like pulmonary exacerbations and weight gain would most likely impede the growth of this market.

This report aims to provide a comprehensive presentation of the global market for Cystic Fibrosis (Mucoviscoidosis) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cystic Fibrosis (Mucoviscoidosis) Testing.

Report Scope

The Cystic Fibrosis (Mucoviscoidosis) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cystic Fibrosis (Mucoviscoidosis) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cystic Fibrosis (Mucoviscoidosis) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cystic Fibrosis (Mucoviscoidosis) Testing Market Report

Report Metric	Details
Report Name	Cystic Fibrosis (Mucoviscoidosis) Testing Market
Segment by Type	Chest Physical Therapy (CPT) Consumption Of Antibiotics Lung Transplant And Postural Drainage
Segment by Application	Hospitals Ambulatory Surgical Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Vertex Pharmaceuticals, Abbott, Pfizer, NovaBiotics, Cystic Fibrosis Foundation, Galapagos
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cystic Fibrosis (Mucoviscoidosis) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cystic Fibrosis (Mucoviscoidosis) Testing Market report?

Ans: The main players in the Cystic Fibrosis (Mucoviscoidosis) Testing Market are Vertex Pharmaceuticals, Abbott, Pfizer, NovaBiotics, Cystic Fibrosis Foundation, Galapagos

What are the Application segmentation covered in the Cystic Fibrosis (Mucoviscoidosis) Testing Market report?

Ans: The Applications covered in the Cystic Fibrosis (Mucoviscoidosis) Testing Market report are Hospitals, Ambulatory Surgical Centers, Others

What are the Type segmentation covered in the Cystic Fibrosis (Mucoviscoidosis) Testing Market report?

Ans: The Types covered in the Cystic Fibrosis (Mucoviscoidosis) Testing Market report are Chest Physical Therapy (CPT), Consumption Of Antibiotics, Lung Transplant And Postural Drainage

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Chest Physical Therapy (CPT)

1.2.3 Consumption Of Antibiotics

1.2.4 Lung Transplant And Postural Drainage

1.3 Market by Application

1.3.1 Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Perspective (2019-2030)

2.2 Cystic Fibrosis (Mucoviscoidosis) Testing Growth Trends by Region

2.2.1 Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cystic Fibrosis (Mucoviscoidosis) Testing Historic Market Size by Region (2019-2024)

2.2.3 Cystic Fibrosis (Mucoviscoidosis) Testing Forecasted Market Size by Region (2025-2030)

2.3 Cystic Fibrosis (Mucoviscoidosis) Testing Market Dynamics

2.3.1 Cystic Fibrosis (Mucoviscoidosis) Testing Industry Trends

2.3.2 Cystic Fibrosis (Mucoviscoidosis) Testing Market Drivers

2.3.3 Cystic Fibrosis (Mucoviscoidosis) Testing Market Challenges

2.3.4 Cystic Fibrosis (Mucoviscoidosis) Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cystic Fibrosis (Mucoviscoidosis) Testing Players by Revenue

3.1.1 Global Top Cystic Fibrosis (Mucoviscoidosis) Testing Players by Revenue (2019-2024)

3.1.2 Global Cystic Fibrosis (Mucoviscoidosis) Testing Revenue Market Share by Players (2019-2024)

3.2 Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cystic Fibrosis (Mucoviscoidosis) Testing Revenue

3.4 Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Concentration Ratio

3.4.1 Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis (Mucoviscoidosis) Testing Revenue in 2023

3.5 Cystic Fibrosis (Mucoviscoidosis) Testing Key Players Head office and Area Served

3.6 Key Players Cystic Fibrosis (Mucoviscoidosis) Testing Product Solution and Service

3.7 Date of Enter into Cystic Fibrosis (Mucoviscoidosis) Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Cystic Fibrosis (Mucoviscoidosis) Testing Breakdown Data by Type

4.1 Global Cystic Fibrosis (Mucoviscoidosis) Testing Historic Market Size by Type (2019-2024)

4.2 Global Cystic Fibrosis (Mucoviscoidosis) Testing Forecasted Market Size by Type (2025-2030)

5 Cystic Fibrosis (Mucoviscoidosis) Testing Breakdown Data by Application

5.1 Global Cystic Fibrosis (Mucoviscoidosis) Testing Historic Market Size by Application (2019-2024)

5.2 Global Cystic Fibrosis (Mucoviscoidosis) Testing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size (2019-2030)

6.2 North America Cystic Fibrosis (Mucoviscoidosis) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2019-2024)

6.4 North America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cystic Fibrosis (Mucoviscoidosis) Testing Market Size (2019-2030)

7.2 Europe Cystic Fibrosis (Mucoviscoidosis) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2019-2024)

7.4 Europe Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Market Size (2019-2030)

8.2 Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Region (2019-2024)

8.4 Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size (2019-2030)

9.2 Latin America Cystic Fibrosis (Mucoviscoidosis) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2019-2024)

9.4 Latin America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Market Size (2019-2030)

10.2 Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2019-2024)

10.4 Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Vertex Pharmaceuticals

11.1.1 Vertex Pharmaceuticals Company Detail

11.1.2 Vertex Pharmaceuticals Business Overview

11.1.3 Vertex Pharmaceuticals Cystic Fibrosis (Mucoviscoidosis) Testing Introduction

11.1.4 Vertex Pharmaceuticals Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)

11.1.5 Vertex Pharmaceuticals Recent Development

11.2 Abbott

11.2.1 Abbott Company Detail

11.2.2 Abbott Business Overview

11.2.3 Abbott Cystic Fibrosis (Mucoviscoidosis) Testing Introduction

11.2.4 Abbott Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)

11.2.5 Abbott Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Detail

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Cystic Fibrosis (Mucoviscoidosis) Testing Introduction

11.3.4 Pfizer Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)

11.3.5 Pfizer Recent Development

11.4 NovaBiotics

11.4.1 NovaBiotics Company Detail

11.4.2 NovaBiotics Business Overview

11.4.3 NovaBiotics Cystic Fibrosis (Mucoviscoidosis) Testing Introduction

11.4.4 NovaBiotics Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)

11.4.5 NovaBiotics Recent Development

11.5 Cystic Fibrosis Foundation

11.5.1 Cystic Fibrosis Foundation Company Detail

11.5.2 Cystic Fibrosis Foundation Business Overview

11.5.3 Cystic Fibrosis Foundation Cystic Fibrosis (Mucoviscoidosis) Testing Introduction

11.5.4 Cystic Fibrosis Foundation Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)

11.5.5 Cystic Fibrosis Foundation Recent Development

11.6 Galapagos

11.6.1 Galapagos Company Detail

11.6.2 Galapagos Business Overview

11.6.3 Galapagos Cystic Fibrosis (Mucoviscoidosis) Testing Introduction

11.6.4 Galapagos Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)

11.6.5 Galapagos Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Vertex Pharmaceuticals

Abbott

Pfizer Inc

NovaBiotics Ltd

Cystic Fibrosis Foundation

Galapagos

List of Tables

Table 1. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Chest Physical Therapy (CPT)

Table 3. Key Players of Consumption Of Antibiotics

Table 4. Key Players of Lung Transplant And Postural Drainage

Table 5. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Region (2019-2024)

Table 9. Global Cystic Fibrosis (Mucoviscoidosis) Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Region (2025-2030)

Table 11. Cystic Fibrosis (Mucoviscoidosis) Testing Market Trends

Table 12. Cystic Fibrosis (Mucoviscoidosis) Testing Market Drivers

Table 13. Cystic Fibrosis (Mucoviscoidosis) Testing Market Challenges

Table 14. Cystic Fibrosis (Mucoviscoidosis) Testing Market Restraints

Table 15. Global Cystic Fibrosis (Mucoviscoidosis) Testing Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Players (2019-2024)

Table 17. Global Top Cystic Fibrosis (Mucoviscoidosis) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing as of 2023)

Table 18. Ranking of Global Top Cystic Fibrosis (Mucoviscoidosis) Testing Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Cystic Fibrosis (Mucoviscoidosis) Testing Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Cystic Fibrosis (Mucoviscoidosis) Testing Product Solution and Service

Table 22. Date of Enter into Cystic Fibrosis (Mucoviscoidosis) Testing Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Cystic Fibrosis (Mucoviscoidosis) Testing Revenue Market Share by Type (2019-2024)

Table 26. Global Cystic Fibrosis (Mucoviscoidosis) Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Cystic Fibrosis (Mucoviscoidosis) Testing Revenue Market Share by Type (2025-2030)

Table 28. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Cystic Fibrosis (Mucoviscoidosis) Testing Revenue Market Share by Application (2019-2024)

Table 30. Global Cystic Fibrosis (Mucoviscoidosis) Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Cystic Fibrosis (Mucoviscoidosis) Testing Revenue Market Share by Application (2025-2030)

Table 32. North America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Cystic Fibrosis (Mucoviscoidosis) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2025-2030) & (US$ Million)

Table 47. Vertex Pharmaceuticals Company Detail

Table 48. Vertex Pharmaceuticals Business Overview

Table 49. Vertex Pharmaceuticals Cystic Fibrosis (Mucoviscoidosis) Testing Product

Table 50. Vertex Pharmaceuticals Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024) & (US$ Million)

Table 51. Vertex Pharmaceuticals Recent Development

Table 52. Abbott Company Detail

Table 53. Abbott Business Overview

Table 54. Abbott Cystic Fibrosis (Mucoviscoidosis) Testing Product

Table 55. Abbott Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024) & (US$ Million)

Table 56. Abbott Recent Development

Table 57. Pfizer Company Detail

Table 58. Pfizer Business Overview

Table 59. Pfizer Cystic Fibrosis (Mucoviscoidosis) Testing Product

Table 60. Pfizer Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024) & (US$ Million)

Table 61. Pfizer Recent Development

Table 62. NovaBiotics Company Detail

Table 63. NovaBiotics Business Overview

Table 64. NovaBiotics Cystic Fibrosis (Mucoviscoidosis) Testing Product

Table 65. NovaBiotics Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024) & (US$ Million)

Table 66. NovaBiotics Recent Development

Table 67. Cystic Fibrosis Foundation Company Detail

Table 68. Cystic Fibrosis Foundation Business Overview

Table 69. Cystic Fibrosis Foundation Cystic Fibrosis (Mucoviscoidosis) Testing Product

Table 70. Cystic Fibrosis Foundation Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024) & (US$ Million)

Table 71. Cystic Fibrosis Foundation Recent Development

Table 72. Galapagos Company Detail

Table 73. Galapagos Business Overview

Table 74. Galapagos Cystic Fibrosis (Mucoviscoidosis) Testing Product

Table 75. Galapagos Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024) & (US$ Million)

Table 76. Galapagos Recent Development

Table 77. Research Programs/Design for This Report

Table 78. Key Data Information from Secondary Sources

Table 79. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Type: 2023 VS 2030

Figure 3. Chest Physical Therapy (CPT) Features

Figure 4. Consumption Of Antibiotics Features

Figure 5. Lung Transplant And Postural Drainage Features

Figure 6. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Application: 2023 VS 2030

Figure 8. Hospitals Case Studies

Figure 9. Ambulatory Surgical Centers Case Studies

Figure 10. Others Case Studies

Figure 11. Cystic Fibrosis (Mucoviscoidosis) Testing Report Years Considered

Figure 12. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Region: 2023 VS 2030

Figure 15. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Players in 2023

Figure 16. Global Top Cystic Fibrosis (Mucoviscoidosis) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Cystic Fibrosis (Mucoviscoidosis) Testing Revenue in 2023

Figure 18. North America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Country (2019-2030)

Figure 20. United States Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Country (2019-2030)

Figure 24. Germany Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Region (2019-2030)

Figure 32. China Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Country (2019-2030)

Figure 40. Mexico Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Country (2019-2030)

Figure 44. Turkey Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Vertex Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)

Figure 47. Abbott Revenue Growth Rate in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)

Figure 48. Pfizer Revenue Growth Rate in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)

Figure 49. NovaBiotics Revenue Growth Rate in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)

Figure 50. Cystic Fibrosis Foundation Revenue Growth Rate in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)

Figure 51. Galapagos Revenue Growth Rate in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions